Entera Bio Ltd. (ENTX) Misses Q2 EPS by 5c

Entera Bio Ltd. (NASDAQ: ENTX) reported Q2 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Entera Bio Ltd. (ENTX) click here.

You May Also Be Interested In

• RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges
• Oppenheimer: 'AAON-branded backlog grew q/q despite increased production, reflecting share gains'
• Bitdeer Technologies Group (BTDR) Misses Q2 EPS by 5c